Total Funding
50
61
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58197
NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases.
Christopher Powala: President & Chief Eexecutive OfficerPast Role: Aclaris Therapeutics, Chief Operating Officer and Chief Development Officer- Mike Wootton: Founder and Chief Executive Officer
About the Company
NFlection Therapeutics is a biopharmaceutical company focusing on targeted treatments for rare diseases. It primarily addresses the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous.
